Drugs / AdimFlu-W (H5N1)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01640691 | Jul 2012 → Jan 2013 | influenza | Adimmune Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdimFlu-W (H5N1) | “A Clinical Study to Evaluate the Immunogenicity and Safety of Pandemic Influenza Vaccine, AdimFlu-W (H5N1), in Healthy Adults” NCT01640691 ↗ |
| Known as | AdimFlu-W (H5N1) Pandemic Influenza Vaccine | “AdimFlu-W (H5N1) Pandemic Influenza Vaccine” NCT01640691 ↗ |
| Modality | Vaccine | “Inactivated whole-virion vaccine” NCT01640691 ↗ |
| Route | Intramuscular | “Administration route: Intramuscular Injection” NCT01640691 ↗ |